modelNoretynodrelAndEstrogen
Extends from Pharmacolibrary.Drugs.ATC.G.G03FA09.
Information
| name: | NoretynodrelAndEstrogen | |
| ATC code: | G03FA09 | route: | oral |
| compartments: | 1 | |
| dosage: | 5 | mg |
| volume of distribution: | 4 | L |
| clearance: | 35 | L/h |
| other parameters in model implementation | ||
Noretynodrel and estrogen is a combination of noretynodrel, a first-generation synthetic progestin, and estrogen (commonly ethinylestradiol or mestranol). It was historically used as an oral contraceptive and for the treatment of menstrual disorders. This combination was among the earliest oral contraceptives introduced but is not commonly used today due to the development of safer alternatives.
Pharmacokinetics
Pharmacokinetic parameters for the noretynodrel and estrogen combination are not reported in the scientific literature. Parameters below are estimated based on typical values for structurally and functionally similar compounds (e.g., norethisterone, ethinylestradiol) in adult healthy female subjects.
References
Zuo, M, et al., & Duan, GL (2005). Stereoselectivity in metabolic 3-reduction of tibolone in healthy Chinese female volunteers. Acta pharmacologica Sinica 26(12) 1527–1530. DOI:10.1111/j.1745-7254.2005.00228.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/16297354
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.9 | Volume of distribution (L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 0.8 | bioavailiability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 20 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1000 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Pharmacolibrary.Types.TransferRate | ka (from PK_1C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_1C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | elimination half-life |
Revisions
- 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)